PATCH TESTING WITH GOLD SALTS - 2 MULTICE NTER STUDIES OF THE GERMAN CONTACT-DERMATITIS RESEARCH GROUP

Citation
P. Koch et al., PATCH TESTING WITH GOLD SALTS - 2 MULTICE NTER STUDIES OF THE GERMAN CONTACT-DERMATITIS RESEARCH GROUP, Hautarzt, 48(11), 1997, pp. 812-816
Citations number
26
Categorie Soggetti
Dermatology & Venereal Diseases
Journal title
ISSN journal
00178470
Volume
48
Issue
11
Year of publication
1997
Pages
812 - 816
Database
ISI
SICI code
0017-8470(1997)48:11<812:PTWGS->2.0.ZU;2-G
Abstract
Between 1992 and 1994 two multicentre studies were performed in order to determine the frequency of sensitization to gold salts. In the firs t study (1992-1993), 872 patients were tested with gold sodium thiosul fate (NTS) 0.25% in Vaseline (V), 0.5% V. and with potassium dicyanoau rate (KDC) 0.002% aqueous solution. 44 patients (5.1%) had a positive patch test reaction to gold salts: 40 (4.6%) to NTS 0.5% V., 20 (2.3%) to NTS 0.25% V. and 5 (0.6%) to KDC. A higher number of positive patc h tests to gold salts was noted in patients also sensitized to another metal salt (8.5%) as compared to those who showed no other sensitivit ies (3.6%). In a second multicentre study (1993-1994), 135 patients wi th associated sensitization to metal salts or intolerance to custom je wellery were tested with the same test series as in the first study an d with gold sodium thiomalate (ATM) 0.25% V. 17 patients (12.6%) had a positive patch test reaction to gold salts: 16 (11.8%) to NTS 0.5% V. , 10 (7.4%) to NTS 0.25% V. and 5 (3.7%) to ATM. The clinical relevanc e of the patch test reactions was considered as being ''probable'' in 5 cases; 1 in the first and 4 in the second study. Considering these r esults, NTS 0.5% V. seems to be the most reliable allergen for detecti ng gold allergy. However, a high proportion of probably false-positive reactions may occur. Further studies are therefore needed to analyze if the high frequency of positive patch tests to NTS 0.5% V. are due t o irritant reactions or to a weak sensitization to gold without clinic al symptoms.